A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer

BACKGROUND: Bone-targeting agents (BTAs), such as bisphosphonates and denosumab, have demonstrated no discernable effects on tumour response or disease free/overall survival in patients with bone metastases from breast cancer. Doxycycline is both osteotropic and has anti-cancer effects. When combine...

Descripción completa

Detalles Bibliográficos
Autores principales: Addison, C.L., Simos, D., Wang, Z., Pond, G., Smith, S., Robertson, S., Mazzarello, S., Singh, G., Vandermeer, L., Fernandes, R., Iyengar, A., Verma, S., Clemons, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154696/
https://www.ncbi.nlm.nih.gov/pubmed/28008379
http://dx.doi.org/10.1016/j.jbo.2016.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154696/
https://www.ncbi.nlm.nih.gov/pubmed/28008379
http://dx.doi.org/10.1016/j.jbo.2016.06.003

Ejemplares similares